Drug profile · INN
collagenase clostridium histolyticum
XIAPEX
collagenase clostridium histolyticum (XIAPEX) is a collagen hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — collagenase clostridium histolyticum
- US status
- approved
- Class
- Musculo-skeletal system (M09)
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
collagenase clostridium histolyticum (XIAPEX) is a collagen hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Collagen hydrolytic enzyme
Primary target: Collagen
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is collagenase clostridium histolyticum?
collagenase clostridium histolyticum (XIAPEX) is a collagen hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for collagenase clostridium histolyticum?
XIAPEX is a marketed brand name for collagenase clostridium histolyticum. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of collagenase clostridium histolyticum?
collagenase clostridium histolyticum has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.